Purpose To compare pharmacokinetic parameters and texture features from two dynamic contrast-enhanced (DCE) MR images [golden-angle radial sparse parallel (GRASP) and view-sharing with golden-angle radial profile (VS-GR) reconstruction], and explore their value in assessing response to neoadjuvant chemotherapy (nCT) in esophageal cancer (EC). Methods The study prospectively enrolled 30 EC patients receiving nCT before surgery. DCE-MRI scanning was performed before nCT and within 1 week before surgery. Chemotherapy response was assessed according to RECIST 1.1 and Tumor Regression Grade (TRG). Mann-Whitney U test was utilized for comparing GRASP and VS-GR reconstruction, and the receiver operating characteristic (ROC) was performed for each significant feature to assess its accuracy in predicting response. Results Among the 30 patients included in this cohort (28 men; average age of 58 ± 8 years), response by RECIST 1.1 demonstrated 18 responders and 12 non-responders. For TRG, no case showed TRG1, 1 patient was TRG2, 3 patients were TRG3, 8 patients were TRG4, and 18 patients were TRG5. A total of 72 pharmacokinetic parameters and texture features were extracted from each tumor. Of those, 29 pre-nCT features and 24 post-nCT features showed statistically significant difference between GRASP and VS-GR reconstruction. One pre-nCT texture feature and 37 post-nCT pharmacokinetic parameters and texture features on VS-GR showed statistically significant differences between responder and non-responders. Both preand post-nCT pharmacokinetic parameters and texture features with GRASP reconstruction showed good performance in response groups (AUC > 0.70, P < 0.05), and only post-nCT pharmacokinetic parameters and texture features with VS-GR reconstruction showed good performance in response groups (AUC > 0.70, P < 0.05). Conclusion GRASP can improve pharmacokinetic parameters and texture features from DCE-MR imaging. Both pre-and post-nCT pharmacokinetic parameters and texture features with GRASP and only post-nCT those with VS-GR reconstruction showed the ability to assess the response to nCT in EC.
Introduction
The incidence rate of esophageal cancer (EC) is rising rapidly worldwide, and it has become the eighth most common cancer [1] . In China, squamous cell carcinoma (SCC) is the main pathological type of EC, and it has high-grade malignancy, rapid progression, poor response to treatment and high recurrence rate [2] . Moreover, the disease is associated with poor prognosis, limited quality of life after surgery [3] and a high incidence of postoperative morbidity and mortality [4] [5] [6] . Preoperative neoadjuvant chemotherapy (nCT) had been shown to have a survival benefit over surgery alone in patients with EC [7, 8] . Nakajima et al. reported that nCT before resection is currently the main treatment for stages II and III SCC, and also suggested that nCT is an optimum treatment strategy if local tumor control is achieved, followed by surgical procedures [6, 9] . Predicting response to nCT accurately helps clinicians to provide the best treatment such as modification of nCT, or termination of nCT to initiate a resection [1, 8] .
FDG-PET seems to be a promising technique for predicting therapeutic response, however, more work is required in standardizing protocols and the time of scanning [10] . Although DCE-MRI had also showed the ability in predicting an early response in EC following 3 weeks of concurrent chemoradiotherapy in limited cases [2, 11] , it remains challenging for predicting response to nCT to find a noninvasive and more effectively imaging tool. Recently, golden-angle radial sparse parallel (GRASP) MRI has gained popularity, and has been applied to imaging of the liver, rectal cancer and renal cell carcinoma [12] [13] [14] [15] . DCE-MRI with GRASP reconstruction may provide more accurately qualitatively information than VS-GR reconstruction.
The objective of this study was to explore the potential value of DCE-MRI with GRASP and the current view-sharing with golden-angle radial profile (VS-GR) reconstruction pre-and post-nCT, and to identify pharmacokinetic parameters and texture features analysis that could potentially be useful for assessing the response to nCT in EC.
Methods and materials
The prospective study was approved by the Ethics Committee, and written informed consent was obtained from all participants. This cohort enrolled patients who received nCT followed by surgical resection. Baseline DCE-MRI was obtained before nCT and a follow-up DCE-MRI was obtained after the nCT completion and within 1 week before surgery. All studies were performed between September 2015 and March 2017. The inclusion criteria were: (1) patients were pathologically confirmed with stage II-III [16, 17] EC by esophagoscopy; (2) patients received clinical and imaging response evaluation at 2 weeks after completing all the treatment courses; (3) all patients received 2 cycles (21 days for each cycle) of nCT (paclitaxel and nedaplatin) before surgery (Fig. 1 ).
Imaging technique
MRI examination was performed on a 3 T MR scanner (MAGNETOM Skyra, Siemens Healthcare) with free breathing dynamic contrast-enhanced radial VIBE using an 18-element body matrix coil and an inbuilt 32-element spine matrix coil. Radial VIBE sequence parameters were following: TR = 3.98 ms, TE = 1.91 ms, flip angle = 12°, acquisition matrix = 300 × 300, FOV = 300 mm × 300 mm × 146 mm, slice thickness = 3 mm, reconstructed image voxel size = 1.0 × 1.0 × 3.0 mm 3 , radial views = 1659, scanning time = 309 s. A total of 68 periods and 4896 images were collected, as every period included 72 images, which covered the whole chest during free breathing. Time resolution of the first 61 periods was 2.4 s, and that of the last 7 periods was 21.7 s. At 20 s after the beginning of scanning, 10-15 mL gadopentetate dimeglumine injection (0.2 ml/kg of body weight, Omniscan, GE Healthcare) was injected at a rate of 2.5 mL/s by a MR-compatible automated doubletube high-pressure injector (Spectris Solaris EP, Medrad), followed by equal volume of normal saline solution to flush the tube.
Clinical response
Clinical response was categorized into four groups on the radial VIBE images by two radiologists with more than 10 years experiences in thorax radiology, according to Fig. 1 Flow chart illustrates patient selection process for study cohort RECIST1.1, and these included complete response (CR): disappearance of all target lesions or lymph nodes < 10 mm in the short axis; partial response(PR): > 30% decrease in sum of longest diameters (SLD) of target lesions, and SLD is the sum of longest diameters (LD) in the three orthogonal directions, progressive disease (PR): > 20% increase in SLD of target lesions with an absolute increase of ≥ 5 mm or the presence of new lesions; and stable disease (SD): none of the above [18, 19] .
Histopathology response
Pathologic response was stratified into five grades by one pathologist with 8 years' experience in esophageal cancer pathology, according to Tumor Regression Grade (TRG) [20] : TRG 1 (complete regression) showed absence of residual cancer and fibrosis extending through the different layers of the esophageal wall; TRG 2 was characterized by the presence of rare residual cancer cells scattered through the fibrosis; TRG 3 was characterized by an increase in the number of residual cancer cells, but fibrosis still predominated; TRG 4 showed residual cancer outgrowing fibrosis; and TRG 5 was characterized by absence of regressive changes.
Image processing and data analysis
From DCE-MRI, 1659 of stack-of-stars views were acquired. These radial views were input into online reconstruction pipeline of view-sharing reconstruction and regrouped into 2 sub-periods (sub-period 1: T0-T61 with a temporal resolution of 2.4 s, sub-period 2 from T62 to T68 with temporal resolution of 21.7 s). GRASPs were performed offline using a home setup of GRASP reconstruction processing pipeline (https ://mrire con.githu b.io/bart/) running on a Yarra server (https ://yarra .rocks ), with the same data but using a temporal resolution of 4.5 s. Details of both reconstructions are summarized in Table 1 .
The images with GRASP and with VS-GR reconstruction were input to the Omni-Kinetics software (GE Medical, China) for pharmacokinetic parameters and texture analysis, separately. Since the esophageal artery is not easy to identify, the thoracic aorta was selected to obtain the arterial input function (AIF).
The 3D-regions of interest (ROI) (Fig. 2) were segmented manually by two radiologists with more than 10 years experiences in thorax radiology, who were blinded to clinical data, to include the entire tumor on each slice pre-and postnCT, except areas of cystic or necrotic degeneration, and normal blood vessels. Tofts model was used to generate the pharmacokinetic parameters. Pharmacokinetic parameters and texture features of 3D-ROI were calculated by OmniKinetics software. Features were categorized into five primary subgroups: (1) 16 pharmacokinetic parameters, (2) 14 first-order, (3) 13 histogram, (4) 13 GLCM, and (5) P 16 RLM.
Statistical analysis
Interobserver reproducibility of radiomic parameters and features extraction was assessed by inter-class correlation coefficients (ICCs). An ICC > 0.75 was considered good agreement. The Mann-Whitney U test of SPSS Statistics version 22 (IBM Corp., Armonk, NY, USA) was used to compare the various parameters and features between GRASP and VS-GR groups, between responder and nonresponder groups, and among the TRG1-5 groups (P < 0.05). The receiver operating characteristic (ROC) was adopted to assess the value of each parameter in predicting response (AUC > 0.70, P < 0.05). Spearman's rank correlation was performed to analyze the correlation between the significant features and response group (P < 0.05). They were stratified into a responder group (CR + PR) and a nonresponder group (SD + PD) according to RECIST1.1, and responder group (TRG1 + 2) and a non-responder group (TRG3 + 4+5) according to TRG. Spearman's correlation coefficients may be interpreted as follows: a correlation coefficient of 0.90-1.00 is considered very high; 0.70-0.89, high; 0.50-0.69, moderate; 0.30-0.49, low; and 0-0.29, negligible [21] .
Results
Among the total of 30 patients (28 men, average age of 58 ± 8 years), 28 patients had SCC, 1 patient had adenocarcinoma and 1 patient had adenosquamous carcinoma (Table 2 ). According to RECIST1.1, 18 cases were considered responders (6 patients with CR and 12 patients with PR) and 12 cases were considered non-responders; all had SD. No patients had PD. For pathologic response, no case showed TRG1, 1 patient had TRG2, 3 patients had TRG3, 8 Figure 2 shows the GRASP's AIF is closer to the true AIF with steeper slope and sharp peak than VS-GR reconstruction. A total of 72 pharmacokinetic parameters and texture features were extracted from each tumor (Table 3) . One pharmacokinetic parameter and 28 texture features pre-nCT were statistically significant (P < 0.05) between GRASP and VS-GR groups. 13 pharmacokinetic parameters and 21 texture features post-nCT were statistically significant (P < 0.05) between GRASP and VS-GR reconstruction groups (Table 4) . Both pre-and post-nCT pharmacokinetic parameters and texture features with GRASP reconstruction showed good performance in response groups (AUC > 0.70, P < 0.05), and only post-nCT pharmacokinetic parameters and texture features with VS-GR reconstruction showed good performance in response groups (AUC > 0.70, P < 0.05) ( Table 5 , Fig. 3 ).
Comparison of GRASP and VS-GR groups

Comparison of responders and non-responders according to RECIST
In comparing pre-nCT texture features between responders and non-responders, 1 VS-GR texture feature (GreyLevelNonuniformity) showed statistically significant difference between the two groups. In comparing post-nCT features between responders and non-responders, 37 pharmacokinetic parameters and the texture features with VS-GR showed significant difference between the two groups (Appendix Table 1 in Supplementary material). Among the 37 pharmacokinetic parameters and texture features, 7 texture features showed good performance (AUC > 0.70, P < 0.025) (Appendix Table 1 in Supplementary material, Fig. 3 ). These included MeanDeviation, Inertia, HaralickCorrelation, LongRunEmphasis, LowGreyLevelRunEmphasis, ShortRunLowGreyLevelEmphasis, LongRunLowGreyLevelEmphasis. The MeanDeviation, Inertia, LongRunEmphasis, LowGreyLevelRunEmphasis, ShortRunLowGreyLevelEmphasis, LongRunLowGreyLevelEmphasis all showed moderate correlation (0.50 ≤ r < 0.70, P < 0.05) between the significant texture features and response groups, and HaralickCorrelation showed low correlation (r = 0.487, P < 0.05) between the significant texture feature and response groups (Table 6) .
One pre-nCT pharmacokinetic parameter (Ktransmedian) and 1 texture feature (HaralickCorrelation) with GRASP reconstruction showed statistically significant difference between responders and non-responders groups (Appendix Table 1 in Supplementary material). Both of these features showed good performance (AUC > 0.70, P < 0.05) (Appendix Table 1 in Supplementary material, Fig. 3 ) and only HaralickCorrelation showed low correlation (r = 0.369, P < 0.05) between the significant texture feature and response groups (Table 6 ). 30 post-nCT pharmacokinetic parameters and texture features with GRASP reconstruction showed statistically significant difference between responders and non-responders (Appendix Table 1 in Supplementary material), and 7/30 texture features showed good performance (AUC > 0.70, P < 0.05) (Appendix Table 1 in Supplementary   Fig. 2 A 71-year-old woman with EC, who was PR and TRG 5. a-f Pre-nCT tumor on radial VIBE image, ROI on the axial image, ROI on reconstructed coronal image, ROI on reconstructed sagittal image, Ktrans and Ve map with VS-GR reconstruction, G-L: the pre-nCT tumor on radial VIBE image, ROI on the axial image, ROI on reconstructed coronal image, ROI on reconstructed sagittal image, Ktrans and Ve map images with GRASP reconstruction. This example shows difference between the GRASP and VS-GR images, although DCE-MRI provided the high image quality material, Fig. 3 ). These included LongRunEmphasis, LowGreyLevelRunEmphasis, ShortRunLowGreyLevelEmphasis, LongRunLowGreyLevelEmphasis showed low correlation (0.30 ≤ r < 0.50) between the significantly different texture features and response groups ( Table 6 ).
Comparison of responders and non-responders according to TRG
There were no significant differences and correlation for all 72 pharmacokinetic parameters and texture features between responder and non-responder groups by using TGR classification.
Discussion
This study demonstrated that GRASP reconstruction may improve the results of DCE-MRI, and pharmacokinetic parameters and texture features may help stratify responders from non-responders in patients with EC treated by nCT. In this study, 29 pre-nCT and 34 post-nCT pharmacokinetic parameters and texture features showed statistically significant differences between GRASP and VS-GR reconstruction.
Post-nCT VS-GR and GRASP features showed more promising between responders and non-responders groups than pre-nCT VS-GR and GRASP features, 37 post-nCT VS-GR features showed statistically significant differences between responders and non-responders groups, with 6/37 showing moderate correlation. On the contrary, 30 post-nCT GRASP features had statistically significant differences, and 4/30 showed low correlation. For pre-nCT analysis, only 1 VS-GR texture feature, 1 GRASP pharmacokinetic parameters and 1 GRASP texture feature also showed statistically Table 5 The AUCs of pre-/post-nCT pharmacokinetic parameters and the texture features with GRASP and VS-GR between responder and nonresponder groups Area means area under receiver operating characteristic curve, and those variables were shown in the significant differences between responders and non-responders groups. DCE-MRI with GRASP reconstruction could provide higher in-plane spatial resolution and near-isotropic resolution [12] . This could potentially result in better acquisition of pharmacokinetic parameters compared to conventional VS-GR DCE-MRI, which has been reported in hepatocellular carcinoma [12] , renal cell carcinoma [15] , and rectal cancer [14] . The AIF for the pharmacokinetic models plays an important role in determining the quantitative measurements of physiological parameters, where small differences in AIF may lead to large differences in quantitative maps and higher temporal resolution normally gives smaller differences than normal temporal resolution.
VS-GR DCE-MRI with three parameters of K trans , K ep and V e had been used in predicting an early response in primary EC patients undergoing concurrent chemoradiotherapy [2] ; however, more texture features have not been used to assess the response to nCT treatment for EC. Although some scholars analyzed texture analysis in EC patients, most studies analyzed CT images, only a few adopted MR images.
Structural heterogeneity is a recognized feature of malignancy and methods for measuring tumor heterogeneity on histological images have been described previously in predicting progression to invasive cancer in patients with Barrett's esophagus [22] and colorectal cancer [23] . Ganeshan B et al. [24] found the potential for CT texture analysis to provide prognostic information. However, very few studies reported the value of texture analysis on CT, highlighting the importance of assessing these features on MRI [24] . The information of whole tumor was assessed rather than a single axial level in our study, which theoretically provides a more representative picture of tumor heterogeneity than that provided by single-level analysis.
Detecting residual cancer postoperatively is critical. Unfortunately, there were no significant differences for those pharmacokinetic parameters and the texture features between TGRs in this study. This may be due to small sample size and uneven pathological grouping between different TRGs. So, the criterion of RECIST is applied to evaluate the efficacy of response according to the changes of tumors in this study, which is also widely used.
There were several limitations in this study. First, small sample size maybe lead to bias, especially, no TRG1. Second, some post-nCT lesions (n = 4) became smaller, maybe some normal esophageal tissue were drawn in the contour. Third, the decision of lumen for measurement, there were 22 patients with EC lesions growing along to the wall. The lumen was removed when measuring the longest diameter of target lesion. 8 lesions showed lump, and the lumen was not taken into account when measuring the longest diameter of target lesions. Finally, 28 patients with SCC and 28 men in 30 patients in this study, which may cause the histological and sex bias, however, this pathological type of SCC consistent with the pathological type of EC in China.
In conclusion, DCE-MRI can monitor the tumor tissue in a noninvasive manner, and thus it may be applied to assess the response to nCT treatment for EC. Furthermore, GRASP reconstruction could provide high temporal frame perfusion imaging and affect the pharmacokinetic parameters and texture features. Additionally, some pre-and post-nCT pharmacokinetic parameters and texture features with GRASP and VS-GR reconstruction may be used to predict tumor response to nCT in EC patients.
